Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
35 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Ductal, Breast"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Condition: Carcinoma, Ductal, Breast
Interventions: Procedure: Biopsy before and after three weeks of study treatment;   Drug: Paclitaxel;   Drug: lapatinib;   Drug: trastuzumab
2 Recruiting Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy
Conditions: Carcinoma, Ductal, Breast;   Menopausal
Intervention: Device: Cryoablation
3 Recruiting Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1
Condition: Invasive Ductal Breast Carcinoma
Interventions: Drug: Carboplatin;   Drug: Abraxane;   Drug: MPDL3280A;   Procedure: Surgery;   Drug: Anthra
4 Recruiting Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)
Conditions: Invasive Ductal Breast Cancer;   Carcinoma Breast Stage I
Intervention: Radiation: Intraoperative Electron Radiotherapy
5 Recruiting Clinical Outcome of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast
Condition: Breast Cancer
Interventions: Drug: Single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate;   Drug: cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate (CDEFM);   Drug: Placebo
6 Recruiting Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Condition: Ductal Breast Carcinoma In Situ
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nelipepimut-S Plus GM-CSF Vaccine;   Biological: Sargramostim
7 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
8 Recruiting G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Conditions: Carcinoma, Ductal, Breast;   Breast Cancer;   Breast Neoplasm
Interventions: Drug: G1T38;   Drug: Fulvestrant
9 Not yet recruiting Tamoxifen Citrate or Afimoxifene in Treating Patients With Estrogen Receptor Positive Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor Positive
Interventions: Drug: Afimoxifene;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Drug: Tamoxifen Citrate
10 Recruiting Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
Conditions: Breast Neoplasm;   Carcinoma, Ductal, Breast;   Carcinoma, Intraductal, Noninfiltrating
Interventions: Procedure: Iron-tracer guided axillary ultrasound and biopsy;   Drug: Iron tracer
11 Recruiting Conjugated Estrogens/Bazedoxifene in Treating Patients With Ductal Carcinoma in Situ Undergoing Surgery
Conditions: Ductal Breast Carcinoma In Situ;   Postmenopausal
Interventions: Drug: Conjugated Estrogens/Bazedoxifene;   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Procedure: Quality-of-Life Assessment;   Other: Questionnaire Administration
12 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)
13 Recruiting Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response to Neoadjuvant Chemotherapy
Conditions: Invasive Ductal Breast Cancer;   Tubular Breast Cancer;   Mucinous Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: 5-fluoruracil
14 Recruiting Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
Conditions: Tubular Breast Cancer;   Mucinous Breast Cancer;   Invasive Ductal Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Gonadotropin-releasing hormone agonist;   Drug: Letrozole
15 Recruiting BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: PI3K inhibitor BYL719;   Drug: letrozole;   Other: laboratory biomarker analysis;   Other: pharmacological studies
16 Recruiting Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Conditions: Breast Cancer;   Ductal Carcinoma;   Invasive Breast Carcinoma;   Invasive Ductal Breast Carcinoma
Interventions: Biological: Talimogene laherparepvec;   Drug: Paclitaxel
17 Recruiting Denosumab as an add-on Neoadjuvant Treatment (GeparX)
Conditions: Breast Cancer Female NOS;   Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Invasive Ductal Breast Cancer;   HER2 Positive Breast Cancer;   Inflammatory Breast Cancer;   Tubular Breast Cancer Stage III
Interventions: Drug: Denosumab;   Drug: nab-Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Carboplatin;   Drug: Trastuzumab;   Drug: Pertuzumab
18 Recruiting A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
Conditions: Tubular Breast Cancer Stage II;   Tubular Breast Cancer Stage III;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   HER2 Positive Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: non-pegylated liposomal doxorubicin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Pertuzumab;   Drug: Trastuzumab;   Drug: Ferric carboxymaltose
19 Recruiting Oxybutynin Chloride in Managing Hot Flashes
Conditions: Bothered by Hot Flashes;   Breast Carcinoma;   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ
Interventions: Drug: Oxybutynin Chloride;   Other: Placebo;   Procedure: Quality-of-Life Assessment;   Other: Questionnaire Administration
20 Recruiting Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: fulvestrant;   Drug: anastrozole

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.